Evidence map›Paper›PMID 10681450›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model.

V M Factor, D Laskowska, M R Jensen, J T Woitach, N C Popescu, S S Thorgeirsson

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 154 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Pathogenesis of Human Immunodeficiency Virus-Journal of clinical medicine · 2020
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

V M FactorLaboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4255, USA.
D Laskowska
M R Jensen
J T Woitach
N C Popescu
S S Thorgeirsson
National Cancer Institute · USNational Institutes of Health · US

Funding

VITAMIN E REDUCES CHROMOSOMAL DAMAGE AND INHIBITS HEPATIC TUMOR FORMATION IN A TRZ01BC010036 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI THORGEIRSSON, SNORRI S · 1996 to 2008
$1.1M
6 · The paper itself

Abstract

We have previously shown that chronic activation of mitogenic signaling induced by over-expression of c-myc and transforming growth factor-alpha (TGFalpha) transgenes in mouse liver induces a state of oxidative stress. We therefore proposed that increased reactive oxygen species (ROS) generation might be responsible for the extensive chromosomal damage and acceleration of hepatocarcinogenesis characteristic for TGFalpha/c-myc mice. In this study, we show that vitamin E (VE), a potent free radical scavenging antioxidant, is able to protect liver tissue against oxidative stress and suppress tumorigenic potential of c-myc oncogene. Dietary supplementation with VE, starting from weaning, decreased ROS generation coincident with a marked inhibition of hepatocyte proliferation while increasing the chromosomal as well as mtDNA stability in the liver. Similarly, dietary VE reduced liver dysplasia and increased viability of hepatocytes. At 6 mo of age, VE treatment decreased the incidence of adenomas by 65% and prevented malignant conversion. These results indicate that ROS generated by over-expression of c-myc and TGFalpha in the liver are the primary carcinogenic agents in this animal model. Furthermore, the data demonstrate that dietary supplementation of VE can effectively inhibit liver cancer development.

Indexed as

alpha-TocopherolAnimalsAntioxidantsDietary SupplementsDisease Models, AnimalDNA DamageDNA, MitochondrialLiverLiver NeoplasmsMiceMice, Inbred C57BLMice, TransgenicReactive Oxygen SpeciesTocopherolsVitamin Ealpha-TocopherolAntioxidantsDNA, MitochondrialReactive Oxygen SpeciesTocopherolsVitamin E

Identifiers

PMID10681450
PMCPMC15777
OpenAlexW2076406046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.